These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9439750)

  • 1. [New neuroleptics improve schizophrenia therapy].
    Nervenarzt; 1997 Dec; 68(12 Suppl Neuartige):1-4. PubMed ID: 9439750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect is effective and free of side effects].
    Psychiatr Prax; 1998 Sep; 25(5 Suppl):1-4. PubMed ID: 9802117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect: effective and free of side effects].
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10 Suppl Schizophre):1-4. PubMed ID: 9828949
    [No Abstract]   [Full Text] [Related]  

  • 4. Sertindole in treating schizophrenia.
    Hosp Med; 1998 Feb; 59(2):165. PubMed ID: 9797900
    [No Abstract]   [Full Text] [Related]  

  • 5. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sertindol, a new atypical neuroleptic drug: improved perspectives for schizophrenic patients].
    Psychiatr Prax; 1997 Nov; 24(6 Suppl Das Atypis):1-4. PubMed ID: 9431363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sertindol, a new atypical neuroleptic drug: improved perspectives for schizophrenic patients].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Das Atypis):1-4. PubMed ID: 9431350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of schizophrenic psychoses: a one-year experience with Serdolect].
    Fortschr Neurol Psychiatr; 1998 Nov; 66(11 Suppl Therapie):1-4. PubMed ID: 9854197
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked elevation of creatine kinase with sertindole: a case report.
    Oulis P; Koulouris GC; Konstantakopoulos G; Masdrakis VG
    Pharmacopsychiatry; 2007 Nov; 40(6):295-6. PubMed ID: 18030658
    [No Abstract]   [Full Text] [Related]  

  • 10. Sertindole versus haloperidol for schizophrenia.
    Mattes JA
    Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
    [No Abstract]   [Full Text] [Related]  

  • 11. Sertindole versus haloperidol for schizophrenia.
    Balon R
    Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we need another atypical antipsychotic?
    Kasper S
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
    Wehnert A
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertindole and impaired atrioventricular function, in the absence of Q-T prolongation: a case report.
    Rizos EN; Leftheriotis D; Douzenis A; Chatziioannou S; Siafakas N; Nika S; Kremastinos D; Lykouras L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442. PubMed ID: 20653911
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction to sertindole in clinical practice.
    Peuskens J
    CNS Drugs; 2004; 18 Suppl 2():1-4. PubMed ID: 15461311
    [No Abstract]   [Full Text] [Related]  

  • 17. Sertindole: a review of clinical efficacy.
    Kane JM
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
    Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Zetidoline in the treatment of schizophrenia--initial experiences].
    Molcan J; Korínková V; Koníková M; Rakús A; Pribyl R
    Cesk Psychiatr; 1984 Jun; 80(3):143-5. PubMed ID: 6148151
    [No Abstract]   [Full Text] [Related]  

  • 20. The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology.
    Peuskens J; Tanghøj P; Mittoux A;
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):425-33. PubMed ID: 18384186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.